Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC-Derived Secretome vs Sodium Hyaluronate in Knee Osteoarthritis
NCT07337863Phase 3Not yet recruiting
- Sponsor
- Universitas Sriwijaya
- Start
- Aug 2026
- Primary completion
- Sep 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Conditioned Medium From Umbilical Cord Mesenchymal Stem Cell Culture Secretome in knee osteoarthritis (OA) (2 arms), sponsored by Universitas Sriwijaya. Primary endpoint: WOMAC Pain Subscale at 24 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Conditioned Medium From Umbilical Cord Mesenchymal Stem Cell Culture Secretome
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07337863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07337863.